| Dr Julie Hutchinson Mcginnis, OD | |
|
2406 W Roosevelt Blvd, Monroe, NC 28110-8430 | |
| (704) 226-1855 | |
| (704) 226-0695 |
| Full Name | Dr Julie Hutchinson Mcginnis |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 15 Years |
| Location | 2406 W Roosevelt Blvd, Monroe, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184855561 | NPI | - | NPPES |
| 1184855561 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2433 (North Carolina) | Secondary |
| 152W00000X | Optometrist | 2009016927 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ryan Leblanc Od Pllc | 4981014164 | 12 |
News Archive
Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
DENTSPLY International Inc. today announced sales and earnings for the three months ended March 31, 2010. Net sales in the first quarter of 2010 increased 7.7% to $545.9 million compared to $506.9 million reported for the first quarter of 2009.
Results from a European Observational Study, which included 1,294 antiretroviral (ARV)-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection (HIV10), demonstrated a low rate of discontinuation and sustained virologic suppression with REYATAZ- (atazanavir)/ritonavir-based regimens over a follow-up period of up to five years.
› Verified 6 days ago
| Provider Name | Premier Family Eye Care Od Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063739274 PECOS PAC ID: 8123159324 Enrollment ID: O20100702000380 |
News Archive
Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
DENTSPLY International Inc. today announced sales and earnings for the three months ended March 31, 2010. Net sales in the first quarter of 2010 increased 7.7% to $545.9 million compared to $506.9 million reported for the first quarter of 2009.
Results from a European Observational Study, which included 1,294 antiretroviral (ARV)-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection (HIV10), demonstrated a low rate of discontinuation and sustained virologic suppression with REYATAZ- (atazanavir)/ritonavir-based regimens over a follow-up period of up to five years.
› Verified 6 days ago
| Provider Name | Ryan Leblanc Od Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992055966 PECOS PAC ID: 4981014164 Enrollment ID: O20201028002159 |
News Archive
Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
DENTSPLY International Inc. today announced sales and earnings for the three months ended March 31, 2010. Net sales in the first quarter of 2010 increased 7.7% to $545.9 million compared to $506.9 million reported for the first quarter of 2009.
Results from a European Observational Study, which included 1,294 antiretroviral (ARV)-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection (HIV10), demonstrated a low rate of discontinuation and sustained virologic suppression with REYATAZ- (atazanavir)/ritonavir-based regimens over a follow-up period of up to five years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie Hutchinson Mcginnis, OD 1614 Belvedere Ave, Charlotte, NC 28205-2914 Ph: (919) 389-5565 | Dr Julie Hutchinson Mcginnis, OD 2406 W Roosevelt Blvd, Monroe, NC 28110-8430 Ph: (704) 226-1855 |
News Archive
Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.
The controversy surrounding GlaxoSmithKline's (GSK) diabetes drug Avandia has been exacerbated by claims from a medical expert that he was threatened with a $4bn lawsuit to try to silence his criticisms of the company's controversial diabetes drug.
Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.
DENTSPLY International Inc. today announced sales and earnings for the three months ended March 31, 2010. Net sales in the first quarter of 2010 increased 7.7% to $545.9 million compared to $506.9 million reported for the first quarter of 2009.
Results from a European Observational Study, which included 1,294 antiretroviral (ARV)-experienced patients presented today at the Tenth International Congress on Drug Therapy in HIV Infection (HIV10), demonstrated a low rate of discontinuation and sustained virologic suppression with REYATAZ- (atazanavir)/ritonavir-based regimens over a follow-up period of up to five years.
› Verified 6 days ago
Aycock Eye Associates Od Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 120 E Phifer Street, Monroe, NC 28110 Phone: 704-283-2179 Fax: 704-283-8314 | |
Ryan Wirkus, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1007 Skyway Dr, Monroe, NC 28110 Phone: 704-289-1547 Fax: 704-291-9441 | |
Dr. John David Aycock, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 808 Circle Dr, Monroe, NC 28112 Phone: 704-283-2179 Fax: 704-283-8314 | |
Tracy Macintyre Raykovicz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2115 W Roosevelt Blvd, Monroe, NC 28110 Phone: 704-238-1849 Fax: 704-238-1850 | |
Dr. Spring Luellen Plihcik, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 630 Comfort Ln, Monroe, NC 28112 Phone: 704-234-1930 Fax: 833-231-6851 | |
Dr. John T. Phifer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 510 S Sutherland Ave, Monroe, NC 28112 Phone: 704-289-6300 Fax: 704-289-8939 |